Medical Devices Startups

Element Science is a medical technology company that develops the Jewel, an FDA-approved adhesive-based wearable cardioverter defibrillator designed to protect patients at risk of sudden cardiac arrest. The device provides continuous monitoring and is currently available in limited U.S. markets.

1 investor

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue. The company serves oncologists and patients to enable personalized cancer treatment selection.

1 investor

Elevate designs and manufactures healthcare products focused on movement and physical health. The company serves patients and clinicians with an emphasis on product function and community engagement.

1 investor

Elevation Spine develops the Saber spinal implant technology, including Saber-C, a zero-profile cervical fusion system combining an anterior cervical plate, interbody, and fixation for less invasive spinal fusion. The products are designed for surgeons performing cervical spine fusion procedures.

1 investor

ElFys develops black silicon photodetector technology for light sensing applications including health monitoring, analytical instrumentation, and security imaging. The Finnish company manufactures photodetectors using proprietary MEMS nanotechnology and atomic layer deposition, with mass production capabilities through both internal facilities and external foundry partnerships.

1 investor

Elgan Pharma is a clinical-stage biopharmaceutical company developing therapies for premature infants and neonates, including treatments for intestinal maturation and retinopathy of prematurity.

1 investor

Elidah develops an FDA-cleared external neuromuscular therapy platform for treating urinary incontinence in women and men, offered through direct-to-consumer and clinical care channels including telehealth and Medicare coverage.

1 investor

ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.

1 investor

EligoChem is a drug discovery company staffed by directors with expertise in medicinal and computational chemistry, biology assay development, and screening.

1 investor

Elle, MD is a female-founded biotechnology company developing Livv, a once-monthly, non-hormonal contraceptive ring that works locally in the reproductive tract to prevent fertilization. It aims to expand the device to include emergency contraception, creating a patient-controlled dual-indication contraceptive for women's reproductive health.

1 investor

Ellen Medical develops affordable dialysis technology for people with end-stage kidney disease, aimed at expanding access to treatment in developing countries where cost currently limits availability.

1 investor

Ellipses Pharma develops cancer treatments targeting unmet clinical needs across various cancer types and molecular mechanisms.

1 investor

Ellis Bio develops genomic and epigenetic analysis technologies for research and diagnostics, leveraging proprietary RNA and DNA methylation research. The company serves biotech and pharmaceutical organizations seeking advanced sequencing and detection capabilities.

1 investor

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics designed to address nonsense mutation genetic disorders. The company is advancing exaluren for rare kidney diseases including Alport syndrome and ADPKD through clinical trials.

1 investor

Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients. The company is a biotechnology spin-off from the Genomac Research Institute.

1 investor

Elucent develops precision-guided surgical technologies that use 3D spatial positioning to make surgical procedures less invasive and more effective. The company serves medical professionals and hospitals seeking to improve surgical outcomes and reduce patient recovery times.

1 investor

Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction. Its allograft products serve surgeons performing reconstructive and cardiovascular repair procedures in the medical device and regenerative medicine field.

1 investor

Emano Flow is a mobile app that uses acoustic technology to objectively measure urinary health symptoms and track patient outcomes before and after medical interventions. It serves urology clinics and healthcare providers seeking objective measurement tools for patient symptom monitoring.

1 investor

Emblation manufactures compact, portable microwave generator systems for medical and industrial applications. The company serves healthcare providers for oncology, cardiology, and other clinical procedures, as well as industrial, scientific, and academic research institutions.

1 investor

Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.

1 investor

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures used to treat conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids. Its Sniper balloon occlusion microcatheter controls blood flow pressure to direct embolic delivery to target tissue while protecting surrounding tissue.

1 investor

EMED makes infusion pump systems and subcutaneous delivery devices for patients requiring immunoglobulin therapy and other biologics. The company's portfolio includes mechanical and electronic infusion pumps, needle sets, and accessories designed for both home and clinical use.

1 investor

Emerald Inno develops a contactless health monitoring device that uses radio wave analysis and machine learning to detect human movement and extract clinical health data without wearables or manual data synchronization. The platform serves clinical research and health studies with proprietary algorithms that process behavioral and movement data.

1 investor

Emerald Technologies provides high-reliability manufacturing, design, and engineering solutions to customers operating in critical programs and end markets. The company serves industrial and defense-focused sectors with specialized technical capabilities.

1 investor